 |
| Screening With the Sub-library of Super-trillion Single Domain Ab Library |
 |
Super large library capacity generates hundreds of lead antibodies |
 |
|
Hundreds of lead antibodies are obtained for regular targets |
|
The superior humanized framework ensures drug developability |
|
Automatic equipment supports diversified cross screenings |
|
Comprehensive validation of pharmaceutical properties with the mammalian cell expressed antibodies |
|
Accelerated antibody discovery process that takes only several weeks |
|
|
|
|
| Core competencies and advantages |
 |
| Advanced technologies and ensured quality |
|
|
|
Trillion-level capacity guarantees delivery |
|
Delivery of up to hundreds of lead antibodies |
|
In-depth humanized antibody frameworks |
|
Extensive epitope coverage by the lead antibodies |
|
Efficacy guaranteed by thorough bio-activity screenings |
|
Comprehensive and diversified screening strategies |
|
|
|
|
|
 |
| One-stop services and highly efficient screening |
|
|
|
Confirmations by professional teams to avoid rework |
|
One-stop services of panning and screenings |
|
Stable and automatic process of high throughput |
|
The fastest delivery in 15 days |
|
Feasible for challenging targets |
|
In-depth verification by nearly 100 projects |
|
|
|
|
|
 |
| Multidimensional characterization to ensure efficacy |
|
|
|
Comprehensive evaluations for multiple types of targets |
|
Reliable validation data with eukaryotic proteins |
|
Comprehensive physiochemical characterization and analysis |
|
Multidimensional detection of affinity kinetics |
|
In vitro and in vivo efficacy validations |
|
Comprehensive function and drug developability analysis |
|
|
|
|
|
 |
| If you would not receive any email service from Sanyou Bio, please UNSUBSCRIBE |